Cargando…

Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2–16 years after successive annual vaccinations with LAIV

BACKGROUND: The UK introduced quadrivalent live attenuated influenza vaccine (qLAIV) for children in 2013/2014. The impact of annual vaccination on effectiveness and immunogenicity is being assessed. METHOD: A phase III/IV open-label study of the immunogenicity of annual vaccination with qLAIV (Flue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoschler, Katja, Maharjan, Sunil, Whitaker, Heather, Southern, Jo, Okai, Blessing, Baldevarona, Janice, Turner, Paul J., Andrews, Nick J., Miller, Elizabeth, Zambon, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054836/ https://www.ncbi.nlm.nih.gov/pubmed/32070679 http://dx.doi.org/10.1016/j.vaccine.2020.02.024

Ejemplares similares

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020)

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

1663. Marked Improvement in Pandemic H1N1 Component Shedding and Immunogenicity in 2017–2018 Russian-Backbone Live Attenuated Influenza Vaccine (LAIV) in Gambian Children
por: Lindsey, Benjamin, et al.
Publicado: (2018)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Serological surveillance of influenza in an English sentinel network: pilot study protocol
por: de Lusignan, Simon, et al.
Publicado: (2019)

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom
por: Jackson, David, et al.
Publicado: (2020)

Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England
por: Yung, Chee-Fu, et al.
Publicado: (2013)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
por: Ang, Jann Catherine, et al.
Publicado: (2019)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Current Opinion in LAIV: A Matter of Parent Virus Choice
por: Kiseleva, Irina
Publicado: (2022)

Cross‐neutralisation of antibodies elicited by an inactivated split‐virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
por: Höschler, Katja, et al.
Publicado: (2008)

985. Safety of Guidelines Recommending LAIV for Routine Use in Children and Adolescents With Asthma
por: Nordin, James, et al.
Publicado: (2018)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
por: Stephenson, Iain, et al.
Publicado: (2009)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011
por: Hoschler, Katja, et al.
Publicado: (2012)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
por: Isakova-Sivak, Irina, et al.
Publicado: (2014)

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
por: Rose, Markus A, et al.
Publicado: (2014)

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults
por: Zhang, Ruiqi, et al.
Publicado: (2023)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation
por: Baguelin, Marc, et al.
Publicado: (2011)

1060 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Bacterial Colonization in Healthy 2-4 Year Old Children. A Randomised Controlled Study
por: Thors, Valtyr, et al.
Publicado: (2014)

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells
por: Shcherbik, Svetlana, et al.
Publicado: (2019)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Estimation of Seasonal Influenza Attack Rates and Antibody Dynamics in Children Using Cross-Sectional Serological Data
por: Minter, Amanda, et al.
Publicado: (2020)

Sensitive and immunogen-specific serological detection of Rodentibacter pneumotropicus infections in mice
por: Fingas, Felix, et al.
Publicado: (2019)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity
por: Hanafusa, Tadashi, et al.
Publicado: (2012)

Immunogenicity and Serological Cross-Reactivity of Saliva Proteins among Different Tsetse Species
por: Zhao, Xin, et al.
Publicado: (2015)

Novel methods of immunogenic antigen selection for serological diagnosis of Parelaphostrongylus tenuis infection
por: Richards, Jessie, et al.
Publicado: (2023)

Safety of live attenuated influenza vaccine in atopic children with egg allergy
por: Turner, Paul J., et al.
Publicado: (2015)

Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
por: Turner, Paul J, et al.
Publicado: (2015)

Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting
por: Laurie, Karen L., et al.
Publicado: (2013)

Our Greatest Tradition: Gathering Together at the Annual Meeting
por: Cava, Kaitlin
Publicado: (2021)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dlf1id5qeifkdlbef66ml5dur7